https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
In 2018 EWGSOP2 has suggested low muscle strength as the primary parameter of sarcopenia. The consensus has recommended SARC-F questionnaire as a screening test to find cases with low muscle strength which has been designated as probable sarcopenia. We aimed to study the ability of SARC-F to find probable sarcopenia cases in older patients. Retrospective, cross-sectional. Istanbul University Istanbul Faculty of Medicine. A total of 456 older adults (71.1% female, mean age 74.6±6.6 years). We diagnosed probable sarcopenia by